Supplementary tables

Practical experimental
General Remarks
Reactions were performed with magnetic stirring under a positive pressure of nitrogen, unless otherwise stated. Chemicals were obtained from commercial suppliers and used as received. Bulk solutions were evaporated under reduced pressure using a Büchi rotary evaporator. All solvents were commercially supplied or dried by filtration through activated alumina (powder ~150 mesh, pore size 58 Å, basic, Sigma-Aldrich) columns. Petrol ether (PE) refers to distilled light petroleum of fraction (30 -40 °C). Flash column chromatography (FCC) was carried out using Merck silica gel 60 (40-63 µm) as stationary phase. 1 All reactions were followed by thin-layer chromatography (TLC) when practical, using Merck Kieselgel 60 F 254 fluorescent treated silica. Visualisation was accomplished under UV light (λ max = 254 nm) and by staining with aqueous potassium permanganate alkaline solution or vanillin staining dip (prepared by adding 2.5 mL of concentrated H 2 SO 4 to a solution of 15 g of vanillin in 250 mL EtOH 95%). Enantiomeric excesses were determined by HPLC analysis on an Agilent 1200 Series instrument using the chiral stationary phase column specified in the individual experiment and by comparing the sample with the appropriate racemic mixture.
NMR spectra were recorded on Bruker spectrometers operating at 400 or 500 MHz ( 1 H resonance).
Proton chemical shifts () are given in parts per million (ppm) relative to tetramethylsilane (TMS) with the solvent resonance as internal standard: 2 CDCl 3 , δ = 7.26 ppm; CD 2 Cl 2 , δ = 5.32 ppm;
(CD 3 ) 2 SO, δ = 2.50 ppm; (CD 3 ) 2 CO, δ = 2.05 ppm. 1 H NMR spectra are reported as follows: ppm (number of protons, multiplicity, coupling constants). The following abbreviations are used to describe spin multiplicity: s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of triplets, m = multiplet, br = broad signal, app = apparent. Coupling constants (J) are given in Hertz (Hz) and are rounded to the nearest integer or half integer. 13 C-NMR spectra were recorded with complete proton decoupling. Carbon chemical shifts are reported in ppm (δ) relative to TMS with the solvent resonance as internal standard:
2 CDCl 3 , δ = 77.16 ppm; CD 2 Cl 2 , δ = 53.84 ppm; (CD 3 ) 2 SO, δ = 39.52 ppm; (CD 3 ) 2 CO, δ = 29.84 ppm. Two-dimensional NMR spectroscopy experiments (COSY, HSQC and HMBC) were used where appropriate to assist in the assignment of signals in 1 H and 13 C spectra and data are not reported.
High resolution mass spectra (HRMS) were recorded by the University of Oxford mass spectrometry staff on a Bruker MicroTOF mass spectrometer equipped with an ESI source or on a Micromass GCT equipped with an EI source.
Infrared absorption spectra (IR) were recorded on a Bruker Tensor 27 FT-IR spectrometer from a compressed sample of the solid or from a thin film (the sample was dissolved in CHCl 3 or acetone and the solvent evaporated) on a diamond ATR module. Bands (ν max ) are reported in wavenumbers (cm -1 ) and their intensity is indicated as strong (s), medium (m) or weak (w).
Optical rotations were recorded using a Perkin Elmer 341 polarimeter. 
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Melting points (m.p.) were recorded using a Reichert hot-stage microscope apparatus equipped with an analogic thermometer (2 °C graduation marks) or a Leica Galen III hot-stage microscope apparatus with digital thermometer and are reported uncorrected.
Compound names are those generated by Reaxys following the IUPAC nomenclature.
N-formyl glycine was synthesized following literature procedures. 3 Amino phosphine L-1 and L-3
were prepared from cinchonine and cinchonidine respectively following literature procedures. 4 Ligands L-2 and L-4 were prepared in an analogous fashion from quinidine and quinine respectively. 5 Methyl isocyanoacetate (7b) is commercially available.
Scheme S1. Overview of the synthesis of isocyanoacetates 7
Synthesis of 2-formamidoacetates 10
tert-Butyl 2-formamidoacetate 6 (10a)
Formamide (45.0 mL, 1.1 mol, 7.4 eq) was added dropwise over 45 minutes to a stirred suspension of NaH (60% dispersion in mineral oil, 6.11 g, 153 mmol, 1.0 eq) in THF (300 mL) at 0 °C. After the addition, the reaction mixture was stirred for 15 minutes at rt, then solvents were removed under reduced pressure. The resulting yellow oil was warmed to 60 °C and tert-butyl bromoacetate (23.0 mL, 153 mmol, 1.0 eq) was added. The reaction mixture was stirred for 16 hours at rt, then saturated Na 2 CO 3 aqueous solution (100 mL) was added and the aqueous layer was extracted with CH 2 Cl 2 (3 × 150 mL). The combined organic phases were washed with water, brine, dried over Na 2 SO 4 , filtered and evaporated. The crude mixture was purified by FCC (from PE/AcOEt 4:1 to AcOEt), obtaining the title compound 10a as a pale yellow oil (17.1 g, 70%). Analytical data are in accordance with those previously reported for this compound. 
Benzyl 2-formamidoacetate (10c)
DCC (3.64 g, 17.6 mmol, 1.0 eq) and DMAP (215 mg, 1.76 mmol, 0.1 eq) were added in sequence to a stirred suspension of N-formyl glycine (2.00 g, 19.4 mmol, 1.1 eq) and benzyl alcohol (1.8 mL, 18 mmol, 1.0 eq) in CH 2 Cl 2 (60 mL) at 0 °C. The reaction mixture was stirred for 16 hours at rt, then the solids were filtered off and solvents were evaporated. Purification of the crude mixture by FCC (PE/AcOEt 1:2) afforded the title compound 10c as a white solid (2.60 g, 76%). Analytical data are in accordance with those previously reported for this compound. The filtrate was washed with water (50 mL) and brine (50 mL), dried over Na 2 SO 4 , filtered and concentrated. Purification of the crude mixture by FCC (PE/AcOEt 1:1) afforded the title compound 10f as a white solid (5.51 g, 68%). Analytical data are in accordance with those previously reported for this compound. 
Synthesis of 2-isocyanoacetates 7
tert-Butyl 2-isocyanoacetate 6 (7a)
POCl 3 (7.48 mL, 80.2 mmol, 1.1 eq) was added dropwise over 20 minutes to a stirred solution of tert-butyl 2-formamidoacetate (10a, 11.6 g, 72.9 mmol, 1.0 eq) and Et 3 N (24.4 mL, 175 mmol, 2.4 eq) in CH 2 Cl 2 (150 mL) at 0 °C. Upon addition the colorless reaction mixture became turbid and turned orange, then brown. After stirring at 0 °C for 15 minutes, saturated NaHCO 3 aqueous solution (100 mL) was added and the phases were separated. The aqueous layer was extracted twice with CH 2 Cl 2 (150 mL), then the collected organic phases were washed with brine, dried over K 2 CO 3 and filtered. Evaporation of solvents afforded a brown oil, which was purified by FCC (PE/AcOEt 4:1). The title compound 7a was obtained as a pale yellow liquid (8.92 g, 87%). Analytical data match the ones previously reported for this compound. 
Benzyl 2-isocyanoacetate 9 (7c)
POCl 3 (1.33 mL, 14.2 mmol, 1.1 eq) was added dropwise over 5 minutes to a stirred solution of benzyl 2-formamidoaceate (10c, 2.50 g, 12.9 mmol, 1.0 eq) and Et 3 N (6.1 mL, 44 mmol, 3.4 eq) in CH 2 Cl 2 (40 mL) at 0 °C. Upon addition the pale yellow solution turned pink, then orange. After stirring at 0 °C for 1.5 hours, a Na 2 CO 3 aqueous solution (4 g in 20 mL of water) was added, the biphasic reaction mixture was stirred at rt for 5 minutes, water (20 mL) was then added and the phases were separated. The aqueous layer was extracted twice with CH 2 Cl 2 (60 mL), then the combined organic phases were washed with brine, dried over K 2 CO 3 and filtered. Evaporation of solvents afforded a brown oil, which was purified by FCC (PE/AcOEt 3:1). The title compound 7c was obtained as a yellow solid (1.88 g, 83%). Analytical data are in accordance with those previously reported for this compound. 
(4-Methoxyphenyl)methyl 2-isocyanoacetate (7d)
POCl 3 (920 µL, 9.86 mmol, 1.1 eq) was added dropwise to a stirred solution of 2-formamidoacetate 10d (2.00 g, 8.96 mmol, 1.0 eq) and Et 3 N (3.0 mL, 22 mmol, 2.4 eq) in CH 2 Cl 2 (45 mL) at 0 °C. After stirring at 0 °C for 2.5 hours, the reaction mixture was quenched by addition of saturated NaHCO 3 aqueous solution (15 mL). The phases were separated and the aqueous layer was extracted with CH 2 Cl 2 (25 mL). The combined organic phases were dried over Na 2 SO 4 , filtered and concentrated. The crude mixture was purified by FCC (CH 2 Cl 2 ), affording the title compound 7d as a yellow solid (1.70 g, 92% 
Diphenylmethyl 2-isocyanoacetate 8 (7f)
A solution of 2-formamidoacetate 10f (4.00 g, 14.8 mmol, 1.0 eq) and Et 3 N (5.0 mL, 36 mmol, 2.4 eq) in CH 2 Cl 2 (75 mL) was cooled to 0 °C, then POCl 3 (1.5 mL, 16 mmol, 1.1 eq) was added dropwise. During the addition the reaction mixture turned yellow. The reaction mixture was stirred at 0 °C for 1.5 hours, then saturated Na 2 CO 3 aqueous solution was added (30 mL) and the phases were separated. The organic layer was washed with water (30 mL), brine (30 mL), dried over Na 2 SO 4 , filtered and concentrated under reduced pressure. The crude mixture was purified by FCC (PE/AcOEt 4:1) affording the title compound 7f as a pale orange solid (3.13 g, 84%). Analytical data are in accordance with those previously reported for this compound. 
Synthesis and characterisation of oxazolines 6
General procedure A for the racemic synthesis of oxazolines 6 Ag 2 O (1.4 mg, 0.00625 mmol, 0.025 eq) was added to a stirred solution of isocyanoacetate 7 (0.250 mmol, 1.0 eq) and 4-nitrobenzaldehyde (8, 42 .0 mg, 0.275 mmol, 1.1 eq) in AcOEt (25 mL). The resulting mixture was stirred at rt until the isocyanoacetate was consumed (as judged by TLC, PE/AcOEt 4:1, developed with vanillin staining dip). The reaction mixture was quickly filtered through Celite ® eluting with AcOEt. The filtrate was concentrated under reduced pressure and purified by FCC (PE/AcOEt) obtaining (±)-6.
General procedure B for the enantioselective synthesis of oxazolines 6
The Obtained according to general procedure B, using L-1 (7.3 mg, 0.0125 mmol, 0.05 eq) and tert-butyl isocyanoacetate 7a (35.3 mg, 0.250 mmol, 1.0 eq). The crude mixture was purified by FCC (from PE/ AcOEt 4:1 to 1:1) obtaining the title compound 6a as an off-white solid (51.1 mg, 70%). Enantiomeric excess (78% ee) was determined by chiral HPLC analysis under the following conditions: 0.5 mg in 1 mL i-PrOH, Chiralpak OD column, hexane/i-PrOH 90:10, flow 1.0 mL/min, λ 254 nm, t (major) = 13.6 min, t (minor) = 16.8 min. 
Methyl (4S,5R)-5-(4-nitrophenyl)-4,5-dihydro-1,3-oxazole-4-carboxylate (6b)
Obtained according to general procedure B, using L-1 (7.3 mg, 0.0125 mmol, 0.05 eq) and methyl isocyanoacetate (26.1 mg, 0.250 mmol, 1.0 eq). The crude mixture was purified by FCC (PE/AcOEt 3:2 to 1:2) obtaining the title compound 6b as a pale yellow oil (50.0 mg, 80%). Enantiomeric excess (82% ee) was determined by chiral HPLC analysis under the following conditions: 0.5 mg in 1 mL i-PrOH, Chiralpak AD column, hexane/i-PrOH 85:15, flow 1.0 mL/min, λ 240 nm, t (minor) = 17.3 min, t (major) = 26.6 min. 1 H NMR is in accordance with that previously reported for this compound. 
Benzyl (4S,5R)-5-(4-nitrophenyl)-4,5-dihydro-1,3-oxazole-4-carboxylate (6c)
Obtained according to general procedure B, using L-1 (7.3 mg, 0.0125 mmol, 0.05 eq) and benzyl isocyanoacetate (7c, 43.8 mg, 0.250 mmol, 1.0 eq). The crude mixture was purified by FCC (PE/AcOEt 4:1 to 3:1) obtaining the title compound 6c as a pale yellow solid (49.8 mg, 61%). Enantiomeric excess (87% ee) was determined by chiral HPLC analysis under the following conditions: 0. [α] D 20 : +142 (c 0.33, AcOEt, sample with 86% ee).
[3,5-Bis(trifluoromethyl)phenyl]methyl (4S,5R)-5-(4-nitrophenyl)-4,5-dihydro-1,3-oxazole-4-carboxylate (6e)
Obtained according to general procedure B, using L-2 (7.7 mg, 0.0125 mmol, 0.05 eq) and isocyanoacetate 7e (77.8 mg, 0.250 mmol, 1.0 eq). The crude mixture was purified by FCC (PE/AcOEt 3:1) obtaining the title compound 6e as a clear oil (64.7 mg, 56%). Enantiomeric excess (84% ee) was determined by chiral HPLC analysis under the following conditions: 0.5 mg in 1 mL i-PrOH/EtOH 1:1, Chiralpak AD column, hexane/i-PrOH 80:20, flow 1 mL/min, λ 254 nm, t (minor) = 8.5 min, t (major) = 11.2 min. 
Diphenylmethyl (4S,5R)-5-(4-nitrophenyl)-4,5-dihydro-1,3-oxazole-4-carboxylate (6f)
Obtained according to general procedure B, using L-2 (7.7 mg, 0.0125 mmol, 0.05 eq) and isocyanoacetate 7f (62. [α] D 20 : +152 (c 0.37, AcOEt, sample with 89% ee).
Diphenylmethyl (4R,5S)-5-(4-nitrophenyl)-4,5-dihydro-1,3-oxazole-4-carboxylate (6f)
Obtained according to general procedure B using L-4 (7.7 mg, 0.0125 mmol, 0.05 eq) and isocyanoacetate 7f (62.8 mg, 0.250 mmol, 1.0 eq), then purified by FCC (from PE/AcOEt 4:1 to PE/AcOEt 3:1) obtaining (4R,5S)-6f as an off-white solid (68.4 mg, 68%). Enantiomeric excess (93% ee) was determined by chiral HPLC analysis under the following conditions: 0.5 mg in 1 mL i-PrOH/EtOH 1:1, Chiralpak OD column, hexane/i-PrOH 85:15, flow 1 mL/min, λ 254 nm, t (minor) = 27.6 min, t (major) = 31.5 min.
[α] D 25 : -156 (c 0.37, AcOEt, sample with 93% ee). S14
Synthesis and characterisation of 5 Diphenylmethyl (2S,3R)-2-amino-3-hydroxy-3-(4-nitrophenyl)propanoate (2S,3R)-(5)
A solution of oxazoline (4S,5R)-6f (683 mg, 1.70 mmol, 1.0 eq) in MeOH (12 mL) was cooled to 0 °C. A solution of thionyl chloride (862 µL, 11.9 mmol, 7.0 eq) in MeOH (12 mL) was cooled to 0 o C and then added dropwise to the reaction flask. The resulting mixture was stirred at 0 °C for 1.5 hours, then quenched by addition of solid NaHCO 3 . Volatiles were removed under reduced pressure and the residue was taken up in CH 2 Cl 2 and water. The phases were separated and the aqueous layer was extracted with CH 2 Cl 2 three times. The combined organic phases were washed with brine, dried over Na 2 SO 4 , filtered and evaporated to obtain a brown oil. Purification of the crude mixture by FCC (PE/AcOEt 3:2 to 1:2) gave the title compound (2S,3R)-5 as a pale yellow solid (499 mg, 75%). Crystallisation was performed as follow. Compound 5 (150.0 mg, 90% ee) was dissolved in toluene (1 mL) at 100 °C, then slowly allowed to cool down to rt. The resulting solution was left for 16 h at 0 °C, then for 4 days at -20 °C, during which a white solid formed. Toluene was removed with a pipette, then the solid was washed with toluene at rt (3 × 1 mL), each time decanting the solvent off. The solid was then dried (92.0 mg, 61% crystallisation yield, 98% ee). 
Diphenylmethyl (2R,3S)-2-amino-3-hydroxy-3-(4-nitrophenyl)propanoate (2R,3S)-(5)
Synthesized and purified in an identical fashion starting from (4R,5S)-6f. The title compound (2R,3S)-5 was obtained as an off-white solid (76%) and was not crystallised. Enantiomeric excess (94%) was determined by chiral HPLC analysis under the following conditions: 0.5 mg in 1 mL i-PrOH/EtOH 1:1, Chiralpak AD column, hexane/i-PrOH 70:30, flow 0.8 mL/min, λ 220 nm, t (minor) = 12.6 min, t (major) = 15.6 min.
[α] D 25 : -31 (c 0.20, AcOEt, sample with 94% ee).
(±)-5 was prepared in an identical fashion from (±)-6f. S15
Synthesis and characterisation of 9 Diphenylmethyl (2S,3R)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propanoate (2S,3R)-(9)
Dichloroacetyl chloride (25 µL, 0.25 mmol, 1.1 eq) was added dropwise to a stirred solution of (2S,3R)-5 (90.0 mg, 0.223 mmol, 1.0 eq) and Et 3 N (35 µL, 0.25 mmol, 1.1 eq) in CH 2 Cl 2 (2.5 mL) at 0 °C. The reaction mixture was stirred at rt for 16 hours, then saturated NaHCO 3 aqueous solution (5 mL) was added. The phases were separated and the aqueous layer was extracted with CH 2 Cl 2 (3 × 5 mL). The combined organic phases were washed with brine, dried over Na 2 SO 4 N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl) 
